The PE Ratio as of September 2024 (TTM) for Corvus Pharmaceuticals, Inc. (CRVS) is -9.60

According to Corvus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.60. This represents a change of 129.92% compared to the average of -4.18 of the last 4 quarters.

Corvus Pharmaceuticals, Inc. (CRVS) Historical PE Ratio (quarterly & annually)

How has CRVS PE Ratio performed in the past?

The mean historical PE Ratio of Corvus Pharmaceuticals, Inc. over the last ten years is -6.71. The current -9.60 PE Ratio has changed 14.21% with respect to the historical average. Over the past ten years (40 quarters), CRVS's PE Ratio was at its highest in in the December 2020 quarter at 0.96. The PE Ratio was at its lowest in in the March 2015 quarter at -38.00.

Corvus Pharmaceuticals, Inc. (CRVS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Corvus Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corvus Pharmaceuticals, Inc. (CRVS) Average PE Ratio

How has CRVS PE Ratio performed in the past?

The current PE Ratio of Corvus Pharmaceuticals, Inc. (CRVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Corvus Pharmaceuticals, Inc. (CRVS) PE Ratio vs. Peers

How is CRVS’s PE Ratio compared to its peers?

Corvus Pharmaceuticals, Inc.’s PE Ratio is greater than Mereo BioPharma Group plc (-18.18), less than Terns Pharmaceuticals, Inc. (-6.06), less than PDS Biotechnology Corporation (-2.64), less than Inozyme Pharma, Inc. (-3.48), less than HOOKIPA Pharma Inc. (-1.22), less than X4 Pharmaceuticals, Inc. (7.41), less than Day One Biopharmaceuticals, Inc. (-7.39), less than Acumen Pharmaceuticals, Inc. (-2.06),

Build a custom stock screener for Corvus Pharmaceuticals, Inc. (CRVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corvus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corvus Pharmaceuticals, Inc. (CRVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corvus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.